These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 38699975
1. Pegylated-interferon alpha (PEG-IFNα)-induced interstitial lung disease in a patient with chronic hepatitis B: A case report and literature review. Shi M, Wang S, Ren Y, Zhao L, Liu M, Yang L, Yang T. Int J Clin Pharmacol Ther; 2024 Aug; 62(8):386-394. PubMed ID: 38699975 [Abstract] [Full Text] [Related]
2. Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. Foster GR, Zeuzem S, Pianko S, Sarin SK, Piratvisuth T, Shah S, Andreone P, Sood A, Chuang WL, Lee CM, George J, Gould M, Flisiak R, Jacobson IM, Komolmit P, Thongsawat S, Tanwandee T, Rasenack J, Sola R, Messina I, Yin Y, Cammarata S, Feutren G, Brown KK. J Viral Hepat; 2013 Apr; 20(4):e115-23. PubMed ID: 23490379 [Abstract] [Full Text] [Related]
3. Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-two case reports. Hegade VS, Sood R, Saralaya D, Moreea S. Ann Hepatol; 2013 Apr; 12(4):629-33. PubMed ID: 23813142 [Abstract] [Full Text] [Related]
4. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C. Chen YC, Lu SN, Lin MC. Chang Gung Med J; 2007 Apr; 30(1):92-7. PubMed ID: 17477035 [Abstract] [Full Text] [Related]
6. Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report. Tamaki K, Okubo A. World J Gastroenterol; 2015 Jan 21; 21(3):1009-13. PubMed ID: 25624738 [Abstract] [Full Text] [Related]
11. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS. Abi-Nassif S, Mark EJ, Fogel RB, Hallisey RK. Chest; 2003 Jul 21; 124(1):406-10. PubMed ID: 12853555 [Abstract] [Full Text] [Related]
12. A case of chronic hepatitis C patient of myocardial ischemia accompanied with interstitial pneumonia induced by pegylated interferon alpha-2a. Qu C, Zheng Z, Liu W, Jiao J, Zhu J. Int J Clin Exp Pathol; 2014 Jul 21; 7(8):5232-5. PubMed ID: 25197402 [Abstract] [Full Text] [Related]
13. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C]. Son BK, Sohn JH, Kim TY, Park YK, Jeon YC, Han DS. Korean J Hepatol; 2007 Mar 21; 13(1):103-7. PubMed ID: 17380081 [Abstract] [Full Text] [Related]
14. Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C. Song JS, Sohn JH, Jeong JY, Min JH, Choi WS, Kim OZ, Pyo JY. Korean J Gastroenterol; 2016 May 25; 67(5):272-276. PubMed ID: 27206440 [Abstract] [Full Text] [Related]
15. The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients. Dogan UB, Golge N, Akin MS. Eur J Gastroenterol Hepatol; 2013 Nov 25; 25(11):1312-6. PubMed ID: 23652913 [Abstract] [Full Text] [Related]